A metabolite produced following consumption of dietary soy may decrease a key risk factor for dementia – with the help of the right bacteria, according to a new discovery.
Traumatic brain injury (TBI) is a leading cause of cognitive impairment that affects millions of people worldwide. Despite growing awareness about the debilitating and lifelong progressive consequences of TBI, there are currently no treatments that slow the deteriorative process. TBI survivors are currently treated with extensive physical and cognitive rehabilitation, accompanied by medications that may mitigate symptoms yet do not halt or slow neurodegeneration. Now, researchers have found for the first time that this process can be pharmacologically reversed in an animal model of this chronic health condition, offering an important proof of principle in the field and a potential path to new therapy.
Keck Medicine of USC enrolling individuals in phase 3 clinical trial to treat mild Alzheimer’s disease using deep brain stimulation.
Older people who report greater levels of social engagement have more robust gray matter in regions of the brain relevant in dementia, according to new research. The findings matter during the COVID-19 pandemic.
Older adults with severe apathy, or lack of interest in usual activities, may have a greater chance of developing dementia than people with few symptoms of apathy, according to a study published in the October 14, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.
With a $17.8 million grant from the National Institute on Aging at the National Institutes of Health, researchers in the Perelman School of Medicine at the University of Pennsylvania will collaborate with 11 research centers to determine more precise diagnostic biomarkers and drug targets for the disease, which affects nearly 50 million people worldwide.
Battling the mild cognitive impairment stage of Alzheimer's may disease may "nip it in the bud".
Misplacing keys, forgetting the way to a doctor's appointment, trouble recalling a neighbor’s name: Are these examples of typical aging? What’s the difference between Alzheimer's disease and other forms of dementia? What's actually happening to the brain, and how can you keep it healthy?
Studying how neurons work together in order to better understand neurological disorders such as Alzheimer’s disease and autism spectrum disorders, researchers led by John Byrne, PhD, at The University of Texas Health Science Center at Houston (UTHealth) have been awarded more than $3 million from the National Institutes of Health BRAIN Initiative.
In a 20-page free special report expert Dr. Mary Newport presents 12 reasons to consider diet ketones to counterattack Mild Cognitive Impairment
A $53.6 million grant from the National Institutes of Health will aid brain scientists, including a researcher from The University of Texas Health Science Center at Houston (UTHealth), in studying the role of incidental white matter lesions, or WMLs, in dementia among diverse people with cognitive complaints.
Sanford Burnham Prebys Medical Discovery Institute today announced that two faculty members, Peter Adams, Ph.D., and Jerold Chun, M.D., Ph.D., have received National Institutes of Health (NIH) Director’s Transformative Research Awards. The awards, which total $8.5 million and are two of only nine granted in 2020, come from the NIH Common Fund’s High-Risk, High-Reward Program.
Researchers at Case Western Reserve University School of Medicine seek to optimize emerging methods of diagnosing two common neurodegenerative diseases—dementia with Lewy bodies and Parkinson’s disease dementia—which affect 1.4 million in the United States
Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert Einstein College of Medicine and Montefiore Health System, has received two grants from the National Institutes of Health totaling $13.8 million to conduct studies on pre-dementia and Alzheimer’s disease.
Could a poo transplant one day be the secret of eternal youth?
New Edith Cowan University (ECU) research has found 94 per cent of Australians caring for a loved one with dementia are sleep deprived.
Patients with mild cognitive impairment can aggressively utilize currently available substances and practices to try and delay their brain degeneration
Subtle differences in cognition may help identify individuals at risk for becoming dependent years later upon others to complete daily activities, such as managing medications or finances and other essential activities.
Findings offer potential target for treating behavioral abnormalities associated with neurodegenerative conditions like Alzheimer’s Disease
Testing a readily and rapidly available, discreet in-vehicle sensing system could provide the first step toward future widespread, low-cost early warnings of cognitive change in older drivers. The use of an advanced, multimodal approach involves the development of novel driving sensors and integration of data from a battery of cognitive function tests, eye tracking and driving behaviors and factors. These in-vehicle technologies could help detect abnormal driving behavior that may be attributed to cognitive impairment.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right